
28 FEBRUARY 2025
What is the hype around India?
In recent years, India has emerged as a pivotal player in the landscape of emerging market equities. Martin Currie provides their perspective on the growth opportunities.

Senior Managing Director, Director of Portfolio Management
Franklin Templeton's association with India dates back over three decades. The firm began investing in Indian markets in 1993 and formally established the India office in 1996 as part of a broader global expansion.
Our team has over 30 years of experience investing in Indian equities. I joined as a portfolio manager at Pioneer ITI, which was acquired by Franklin Templeton in 2002. At Pioneer ITI, I helped design the investment philosophy and process behind the Franklin India Equity strategy in the mid-1990s – a framework we’ve consistently followed ever since.
We are a dedicated India equity specialist team, comprising 18 investment professionals, 17 of whom are based in India and focused exclusively on Indian equities. This local presence has enabled us to build deep knowledge of the asset class and longstanding relationships with companies – advantages that are difficult to replicate.
The Franklin India Fund launched in 2005. I am the lead manager, supported by Murali Yerram and Arya Sen, who contribute ideas to the portfolio. We draw stock ideas from company recommendations made by our India-based analysts.
The strategy focuses on quality and sustainable growth at discounted valuations. We take a medium-to-long term view, aiming to generate value for our investors over time by investing in companies with enduring fundamentals.
We look for quality businesses that consistently generate superior profitability, maintain healthy balance sheets, and demonstrate sustainable competitive advantages. Management quality is a key criterion – we seek companies with leadership teams that have a clear strategic vision and the ability to position for the future.
Importantly, we’re valuation conscious. Even great company companies must be purchased at the right price – what we refer to as “discount to intrinsic worth”.
We aim to identify companies whose intrinsic worth is not reflected in their market price. This margin of safety often stems from qualitative factors – such as a company’s ability to maintain quality, sustainability, and growth – which we believe the market may underappreciate.
Traditional valuation metrics like price-to-earnings or price-to-book1 can be limited by accounting standards and may not reveal the full picture. A company might not appear cheap on these metrics, yet our in-house assessment could suggest significant upside. These are inefficiencies we seek to exploit.
Proprietary fundamental research is the foundation of our process. Our analysts conduct rigorous quantitative and qualitative assessments to evaluate growth potential, competitive positioning, risks and catalysts for value recognition.
Company meetings are essential. We engage with management, staff, competitors, clients, suppliers, and other stakeholders to uncover insights that go beyond financial statements. Our presence in India enables us to conduct 600 to 800 company meetings annually, giving us timely access to local developments and deeper industry knowledge.
We manage a high-conviction strategy using bottom-up stock selection to build a relatively concentrated portfolio of 40-60 holdings. While focused, we diversify the portfolio across sectors and drivers of return.
The fund aims to achieve long-term capital growth by investing in companies of any size that are either based in India or generate most of their business there.
Investors are beginning to take note of India as a pivotal player in emerging market equities. Let’s take a closer look at some of the big picture themes driving inflows into India mutual funds and India ETFs
1. For more information on terms used within this page, please refer to our glossary.
What are the Key Fund Risks?
Franklin India Fund
The value of shares in the Fund and income received from it can go down as well as up and investors may not get back the full amount invested. Performance may also be affected by currency fluctuations. Currency fluctuations may affect the value of overseas investments. The Fund invests mainly in equity and equity-related securities of a single emerging country. Such Indian securities have historically been subject to significant price movements, frequently to a greater extent than equity markets globally. As a result, the performance of the Fund can fluctuate significantly over relatively short time periods.
Other significant risks include:
Foreign Currency risk: the risk of loss arising from exchange-rate fluctuations or due to exchange control regulations.
Emerging markets risk: the risk related to investing in countries that have less developed political, economic, legal and regulatory systems, and that may be impacted by political/economic instability, lack of liquidity or transparency, or safekeeping issues.
Liquidity risk: the risk that arises when adverse market conditions affect the ability to sell assets when necessary. Such risk may be triggered by (but not limited to) unexpected events such as environmental disasters or pandemics. Reduced liquidity may have a negative impact on the price of the assets.
For full details of all of the risks applicable to this Fund, please refer to the “Risk Considerations” section of the Fund in the current prospectus of Franklin Templeton Investment Funds.
Important Legal Information
Subscriptions to shares of the Fund can only be made on the basis of the current prospectus and where available, the relevant Key Investor Information Document, accompanied by the latest available audited annual report and the latest semi-annual report if published thereafter.
No shares of the Fund may be directly or indirectly offered or sold to residents of the United States of America. Shares of the Fund are not available for distribution in all jurisdictions and prospective investors should confirm availability with their local Franklin Templeton representative before making any plans to invest. References to particular industries, sectors or companies are for general information and are not necessarily indicative of a Fund’s holding at any one time. The value of shares in the Fund and income received from it can go down as well as up, and investors may not get back the full amount invested. All or most of the protections provided by the UK Regulatory System will not apply to Franklin Templeton Investment Funds (SICAV) Investors. An investment in the Fund entails risks which are described in the Fund’s prospectus and where available, in the relevant Key Investor Information Document.
There is no guarantee that the Fund will achieve its objective. A copy of the latest prospectus, and if available for this product the Key Investor Information Document, the annual report and semi-annual report, if published thereafter can be found, on our website www.franklintempleton.co.uk or can be obtained, free of charge, from Franklin Templeton Investment Management Limited, Cannon Place, 78 Cannon Street, London EC4N 6HL. Telephone: 0800 313 4049, Email: [email protected].
The Fund's documents are available in English, Arabic, French, German, Italian, Polish and Spanish. In addition, a Summary of Investor Rights is available from www.franklintempleton.lu/summary-of-investor-rights. The summary is available in English. The sub-funds of FTIF are notified for marketing in multiple EU Member States under the UCITS Directive. FTIF can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive.
For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the Fund and will not be investing directly in the underlying assets of the Fund.
This document is intended to be of general interest only and does not constitute legal or tax advice nor is it an offer for shares or invitation to apply for shares of the Franklin Templeton Investment Funds SICAV (“the Fund”). Nothing in this document should be construed as investment advice. Opinions expressed are the author's at publication date and they are subject to change without prior notice.
Issued by Franklin Templeton Investment Management Limited (FTIML). FTIML is authorised and regulated by the Financial Conduct Authority.